S1523 Absence of Pseudopolyps and Submucosal Edema on Abdominopelvic CT Are Associated With Increased Mortality in Toxic Megacolon

Introduction: Toxic megacolon (TM) is a rare, life-threatening complication of inflammatory bowel disease (IBD) and other etiologies. While diagnosis has classically relied on radiographic imaging, few studies have explored the role of computed tomography (CT) in TM. This study aims to describe common CT findings in TM, their prevalence across TM etiologies, and their impact on clinical outcomes. Methods: We conducted a retrospective analysis of patients ≥18 years old with TM from January 2014 to June 2024 using International Classification of Diseases-9/10 codes across 1,238 Banner Health sites. Patients with verified TM who underwent contrast-enhanced abdominopelvic CT within 48 hours of diagnosis were included. Data on TM etiologies, demographics, clinical features, and treatment were collected. CT images were reviewed by an abdominal radiologist blinded to imaging reports. The primary outcome was 30-day mortality. Statistical analysis included Fisher’s exact test and ANOVA. Results: We identified 70 patients with TM who underwent CT (median age 62 years, 42.9% female, 71.4% non-Hispanic White). TM etiologies included Clostridioides difficile (C. diff) (38.6%), ischemic colitis (IsC) (28.6%), IBD (25.7%), and others (7.7%). The most common CT findings included loss of haustra (95.7%), colonic distention >6 cm (94.3%), colonic wall thickening (85.7%), peri-colonic fat stranding (85.7%), submucosal edema (50%), colonic wall thinning (45.7%), ascites (42.9%), small bowel distention (20%), and pseudopolyps (12.9%). The median colonic diameter was 8.8 cm. Loss of haustra was less common in IsC (85% vs 100% for IBD vs 100% for C. diff, P = 0.045) while pseudopolyps were more common in IBD (33.3% vs 3.7% for C. diff vs 5% for IsC, P = 0.008). Pneumatosis coli was more common in IsC (20% vs 5.6% for IBD vs 0% for C. diff, P = 0.041). The colon perforation rate was 28.6% (N = 20); 9 perforations were detected via imaging. The colectomy rate was 55.7%. The 30-day mortality rate was 32.9% (N = 23). The absence of pseudopolyps (37.7% vs 0%, P = 0.025) and submucosal edema (45.7% vs 20%, P = 0.041) were associated with increased 30-day mortality. Conclusion: We identified several common CT findings in TM. While IsC was linked to pneumatosis coli, IBD and C. diff were more commonly associated with sequelae of chronic inflammation. The absence of submucosal edema and pseudopolyps are associated with increased mortality in TM. Additional studies are needed to further assess the role of CT in TM diagnosis, treatment, and impact on outcomes.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001133552.20793.60
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1523 Absence of Pseudopolyps and Submucosal Edema on Abdominopelvic CT Are Associated With Increased Mortality in Toxic Megacolon

Sasha Taleban, Christopher Miller, Joseph Gunderson, Chiu‐Hsieh Hsu et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

S1523 Absence of Pseudopolyps and Submucosal Edema on Abdominopelvic CT Are Associated With Increased Mortality in Toxic Megacolon

Sasha Taleban, Christopher Miller, Joseph Gunderson, Chiu‐Hsieh Hsu, Fabrina Hossain, David J. Schaub, Alisia C. Gunderson
article en

Abstract

Introduction: Toxic megacolon (TM) is a rare, life-threatening complication of inflammatory bowel disease (IBD) and other etiologies. While diagnosis has classically relied on radiographic imaging, few studies have explored the role of computed tomography (CT) in TM. This study aims to describe common CT findings in TM, their prevalence across TM etiologies, and their impact on clinical outcomes. Methods: We conducted a retrospective analysis of patients ≥18 years old with TM from January 2014 to June 2024 using International Classification of Diseases-9/10 codes across 1,238 Banner Health sites. Patients with verified TM who underwent contrast-enhanced abdominopelvic CT within 48 hours of diagnosis were included. Data on TM etiologies, demographics, clinical features, and treatment were collected. CT images were reviewed by an abdominal radiologist blinded to imaging reports. The primary outcome was 30-day mortality. Statistical analysis included Fisher’s exact test and ANOVA. Results: We identified 70 patients with TM who underwent CT (median age 62 years, 42.9% female, 71.4% non-Hispanic White). TM etiologies included Clostridioides difficile (C. diff) (38.6%), ischemic colitis (IsC) (28.6%), IBD (25.7%), and others (7.7%). The most common CT findings included loss of haustra (95.7%), colonic distention >6 cm (94.3%), colonic wall thickening (85.7%), peri-colonic fat stranding (85.7%), submucosal edema (50%), colonic wall thinning (45.7%), ascites (42.9%), small bowel distention (20%), and pseudopolyps (12.9%). The median colonic diameter was 8.8 cm. Loss of haustra was less common in IsC (85% vs 100% for IBD vs 100% for C. diff, P = 0.045) while pseudopolyps were more common in IBD (33.3% vs 3.7% for C. diff vs 5% for IsC, P = 0.008). Pneumatosis coli was more common in IsC (20% vs 5.6% for IBD vs 0% for C. diff, P = 0.041). The colon perforation rate was 28.6% (N = 20); 9 perforations were detected via imaging. The colectomy rate was 55.7%. The 30-day mortality rate was 32.9% (N = 23). The absence of pseudopolyps (37.7% vs 0%, P = 0.025) and submucosal edema (45.7% vs 20%, P = 0.041) were associated with increased 30-day mortality. Conclusion: We identified several common CT findings in TM. While IsC was linked to pneumatosis coli, IBD and C. diff were more commonly associated with sequelae of chronic inflammation. The absence of submucosal edema and pseudopolyps are associated with increased mortality in TM. Additional studies are needed to further assess the role of CT in TM diagnosis, treatment, and impact on outcomes.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.